PRLB · Proto Labs Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $75.74M | - | $74.07M | $75.29M | $70.51M | - | $68.39M | $69.08M | $70.42M | - |
| Gross Profit | $63.59M | - | $61.29M | $59.77M | $55.70M | - | $57.23M | $56.55M | $57.47M | - |
| R&D | $10.54M | - | $10.71M | $11.17M | $10.61M | - | $9.77M | $10.66M | $11.17M | - |
| SG&A | $17.01M | - | $17.16M | $18.75M | $16.85M | - | $16.26M | $16.59M | $16.31M | - |
| Total Operating Expenses | $53.75M | - | $52.48M | $54.80M | $51.17M | - | $48.65M | $50.55M | $50.64M | - |
| D&A | $8.07M | - | $8.91M | $8.97M | $8.69M | - | - | - | $9.10M | - |
| Operating Income | $9.84M | - | $8.81M | $4.97M | $4.53M | - | $8.58M | $6.00M | $6.83M | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $3.21M | - | $3.04M | $2.25M | $2.39M | - | $2.68M | $2.82M | $2.46M | - |
| Net Income | $8.11M | - | $7.22M | $4.43M | $3.60M | - | $7.19M | $4.54M | $5.27M | - |
| EPS - Basic | $0.34 | - | $0.30 | $0.19 | $0.15 | - | $0.29 | $0.18 | $0.21 | - |
| EPS - Diluted | $0.33 | - | $0.30 | $0.18 | $0.15 | - | $0.29 | $0.18 | $0.20 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $123.97M | $110.83M | $104.42M | $90.38M | $82.69M | $89.07M | $87.87M | $96.15M | $92.80M | $83.79M |
| Accounts Receivable | $85.55M | $78.96M | $77.79M | $78.01M | $73.90M | $66.50M | $69.46M | $70.89M | $77.85M | $72.85M |
| Inventory | $14.87M | $14.40M | $14.07M | $13.17M | $13.20M | $12.30M | $12.41M | $12.36M | $12.82M | $13.66M |
| Accounts Payable | $19.63M | $15.10M | $17.39M | $15.58M | $16.29M | $15.50M | $15.00M | $15.91M | $15.26M | $15.64M |
| Current Assets | $248.58M | $233.54M | $225.79M | $205.51M | $194.41M | $194.85M | $193.07M | $207.62M | $210.42M | $200.66M |
| Total Assets | $778.57M | $763.41M | $756.86M | $743.25M | $737.45M | $743.51M | $753.79M | $758.21M | $769.80M | $772.35M |
| Current Liabilities | $70.72M | $67.00M | $69.74M | $62.16M | $62.09M | $53.27M | $53.76M | $50.95M | $58.44M | $49.68M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $95.44M | $89.48M | $92.14M | $78.55M | $80.65M | $73.36M | $73.79M | $72.97M | $82.49M | $77.06M |
| Stockholders' Equity | $683.13M | $673.93M | $664.72M | $664.71M | $656.80M | $670.15M | $679.99M | $685.24M | $687.31M | $695.29M |
| Retained Earnings | $248.88M | $240.76M | $238.57M | $239.34M | $236.55M | $244.41M | $252.79M | $253.24M | $253.41M | $256.40M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $17.54M | - | - | - | $18.38M | - | - | - | $21.34M | - |
| Investing Cash Flow | ($4.77M) | - | - | - | ($2.91M) | - | - | - | $4.42M | - |
| Financing Cash Flow | $658.0K | - | - | - | ($21.93M) | - | - | - | ($16.62M) | - |
| CapEx | $3.54M | - | - | - | $1.26M | - | - | - | $2.59M | - |
| Free Cash Flow | $14.00M | - | - | - | $17.12M | - | - | - | $18.75M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | 1.73 | - | - | - | 4.76 | - | - | - | 3.56 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | 28.3% | - | 29.6% | 33.7% | 39.9% | - | 27.1% | 38.3% | 31.8% | - |
| Return on assets | 1.0% | - | 1.0% | 0.6% | 0.5% | - | 1.0% | 0.6% | 0.7% | - |
| Return on equity | 1.2% | - | 1.1% | 0.7% | 0.5% | - | 1.1% | 0.7% | 0.8% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 3.51 | 3.49 | 3.24 | 3.31 | 3.13 | 3.66 | 3.59 | 4.08 | 3.60 | 4.04 |
| Quick ratio | 3.30 | 3.27 | 3.04 | 3.09 | 2.92 | 3.43 | 3.36 | 3.83 | 3.38 | 3.76 |
| Cash ratio | 1.75 | 1.65 | 1.50 | 1.45 | 1.33 | 1.67 | 1.63 | 1.89 | 1.59 | 1.69 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.14 | 1.13 | 1.14 | 1.12 | 1.12 | 1.11 | 1.11 | 1.11 | 1.12 | 1.11 |
| Liabilities / Assets | 0.12 | 0.12 | 0.12 | 0.11 | 0.11 | 0.10 | 0.10 | 0.10 | 0.11 | 0.10 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | 5.09 | - | 5.26 | 5.72 | 5.34 | - | 5.51 | 5.59 | 5.49 | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | 72d | - | 69d | 64d | 68d | - | 66d | 65d | 66d | - |
| Days payable outstanding | 95d | - | 86d | 76d | 84d | - | 80d | 84d | 79d | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 172.8x | - | 166.8x | 222.4x | 233.6x | - | 101.3x | 171.6x | 178.8x | - |
| P / B | 2.0x | - | 1.8x | 1.5x | 1.3x | - | 1.1x | 1.1x | 1.3x | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | 70.4x | - | 62.4x | 62.7x | 58.5x | - | - | - | 52.0x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | 14.2% | - | 7.1% | 5.7% | -3.1% | - | -3.5% | 6.4% | 6.9% | - |
| Operating income growth (YoY) | 117.1% | - | 2.7% | -17.2% | -33.6% | - | -17.6% | 7.0% | 82.1% | - |
| Net income growth (YoY) | 125.4% | - | 0.4% | -2.5% | -31.7% | - | -9.6% | - | 98.1% | - |
| EPS growth (YoY) | 120.0% | - | 3.4% | 0.0% | -25.0% | - | -6.5% | - | 100.0% | - |
| EPS CAGR (3y) | 48.9% | - | 28.9% | 26.0% | -7.6% | - | 19.5% | -27.4% | 15.4% | - |
| EPS CAGR (5y) | 20.5% | - | -11.4% | -17.5% | -22.0% | - | -14.1% | -21.4% | -18.9% | - |
| FCF growth (YoY) | -18.2% | - | - | - | -8.7% | - | - | - | -2.0% | - |
| FCF CAGR (5y) | - | - | - | - | 13.7% | - | - | - | 28.9% | - |
| Book value growth (YoY) | 4.0% | 0.6% | -2.2% | -3.0% | -4.4% | -3.6% | -0.7% | 0.4% | 0.6% | -0.3% |
Peer comparison
Same SIC group: Fabricated Structural Metal Products
Comparing Proto Labs Inc against the 5 most active filers in the same SIC group.